|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-9-2
|
|
pubmed:abstractText |
To determine the maximum tolerated dose (MTD), the dose-limiting toxicity (DLT) and the recommended dose of docetaxel in combination with doxorubicin, and to evaluate the activity in patients with advanced breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AusselJ PJP,
pubmed-author:AzliNN,
pubmed-author:BeuzebocPP,
pubmed-author:BourgeoisHH,
pubmed-author:BozekTT,
pubmed-author:CvitkovicEE,
pubmed-author:DierasVV,
pubmed-author:GruiaGG,
pubmed-author:JasminCC,
pubmed-author:KalleWW,
pubmed-author:MissetJ LJL,
pubmed-author:PouillartPP,
pubmed-author:RivaAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
553-60
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10416005-Adult,
pubmed-meshheading:10416005-Aged,
pubmed-meshheading:10416005-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10416005-Breast Neoplasms,
pubmed-meshheading:10416005-Doxorubicin,
pubmed-meshheading:10416005-Female,
pubmed-meshheading:10416005-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:10416005-Heart Failure,
pubmed-meshheading:10416005-Humans,
pubmed-meshheading:10416005-Middle Aged,
pubmed-meshheading:10416005-Paclitaxel,
pubmed-meshheading:10416005-Taxoids,
pubmed-meshheading:10416005-Ventricular Function, Left
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer.
|
|
pubmed:affiliation |
Hôpital Paul Brousse, Villejuif, France. jean-louis.misset@pbr.ap-hop-paris.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
